As expected, the levels of monocyte and neutrophil inflammation markers (soluble CD14 (sCD14) and myeloperoxidase (MPO)) were increased in the severe group compared with mild and control groups, alluding to the association between microbial translocation and COVID-19 severity. Here, MPO is linked to COVID-19.